Loading…
CIK 0001056807 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("bvf-inc-il","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | $34.7M | 1.2%Prev: 1.6% | 4,629,289 SH | Decreased |
| ABIVAX SA | SPONSORED ADS | $68.5M | 2.3%Prev: 1.9% | 508,031 SH | Increased-50,000 SH |
| AC IMMUNE SA | SHS | $62.2M | 2.1%Prev: 2.3% | 19,822,436 SH | Increased |
| ANNEXON INC | COM | $45.8M | 1.5%Prev: 0.9% | 9,128,080 SH | Increased+2,128,080 SH |
| AVALO THERAPEUTICS INC | COM NEW | $24.6M | 0.8%Prev: 0.7% | 1,355,257 SH | Increased+1 SH |
| AXSOME THERAPEUTICS INC | COM | $8.4M | 0.3%Prev: 2.4% | 45,757 SH | Decreased-441,000 SH |
| COMPASS THERAPEUTICS INC | COM | $41.7M | 1.4%Prev: 0.7% | 7,764,842 SH | Increased+3,014,842 SH |
| CRESCENT BIOPHARMA INC. | COM | $32.6M | 1.1%Prev: 0.7% | 2,748,763 SH | Increased+1,360,900 SH |
| CULLINAN THERAPEUTICS INC | COM | $59.5M | 2.0%Prev: 1.4% | 5,750,683 SH | Increased |
| DISC MEDICINE INC | COM | $51.6M | 1.7% | 650,000 SH | New |
| ELEDON PHARMACEUTICALS INC | COM | $9.5M | 0.3%Prev: 0.7% | 6,293,282 SH | Decreased |
| ENGENE HOLDINGS INC | *W EXP 10/31/202 | $2.4M | 0.1%Prev: 0.0% | 945,402 SH | Increased |
| FOGHORN THERAPEUTICS INC | COM | $28.6M | 1.0%Prev: 1.1% | 5,302,000 SH | Increased |
| GH RESEARCH PLC | ORDINARY SHARES | $112.1M | 3.8%Prev: 5.1% | 8,827,712 SH | Decreased |
| IMAGENEBIO INC | COM | $5.5M | 0.2%Prev: 0.3% | 802,102 SH | Decreased |
| IMMUNIC INC | COM | $4.1M | 0.1%Prev: 0.3% | 7,652,972 SH | Decreased |
| IMMUNOCORE HLDGS PLC | ADS | $50.3M | 1.7%Prev: 2.3% | 1,488,975 SH | Decreased-85,313 SH |
| INVENTIVA SA | ADS | $3.2M | 0.1%Prev: 0.2% | 686,040 SH | Decreased |
| INVIVYD INC | COM | $48.2M | 1.6% | 19,525,000 SH | New |
| KURA ONCOLOGY INC | COM | $89.5M | 3.0%Prev: 3.1% | 8,617,162 SH | Increased |
| KYMERA THERAPEUTICS INC | COM | $428.2M | 14.4%Prev: 12.6% | 5,502,710 SH | Increased |
| MIRUM PHARMACEUTICALS INC | COM | $118.1M | 4.0%Prev: 4.4% | 1,495,290 SH | Increased |
| MOLECULAR PARTNERS AG | ADS | $5.8M | 0.2%Prev: 0.2% | 1,353,968 SH | Increased |
| MONTE ROSA THERAPEUTICS INC | COM | $60.1M | 2.0%Prev: 1.7% | 3,835,886 SH | Increased-1,824,246 SH |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $260.3M | 8.8%Prev: 5.7% | 19,751,284 SH | Increased |
| NEKTAR THERAPEUTICS | COM NEW | $65.9M | 2.2%Prev: 2.9% | 1,559,595 SH | Decreased+283,000 SH |
| OLEMA PHARMACEUTICALS INC | COM | $132.4M | 4.5%Prev: 2.1% | 5,295,893 SH | Increased |
| PALVELLA THERAPEUTICS INC NE | COM | $92.0M | 3.1%Prev: 3.0% | 879,009 SH | Increased-282,240 SH |
| PEPGEN INC | COM | $12.5M | 0.4%Prev: 0.4% | 1,915,000 SH | Increased |
| REPARE THERAPEUTICS INC | COM | $26.9M | 0.9%Prev: 0.7% | 10,333,600 SH | Increased |
| REVOLUTION MEDICINES INC | COM | $267.4M | 9.0%Prev: 7.5% | 3,356,782 SH | Increased-618,131 SH |
| SEPTERNA INC | COM | $48.0M | 1.6%Prev: 3.1% | 1,720,782 SH | Decreased-2,295,008 SH |
| STOKE THERAPEUTICS INC | COM | $71.9M | 2.4%Prev: 1.6% | 2,265,674 SH | Increased+608,578 SH |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $242.0M | 8.1%Prev: 3.6% | 3,479,022 SH | Increased+275,105 SH |
| TENAX THERAPEUTICS INC | COM NEW | $4.1M | 0.1%Prev: 0.1% | 339,549 SH | Increased |
| TSCAN THERAPEUTICS INC | COM | $5.2M | 0.2%Prev: 0.4% | 5,226,074 SH | Decreased |
| TYRA BIOSCIENCES INC | COM | $55.9M | 1.9%Prev: 2.1% | 2,127,665 SH | Increased-1,522,129 SH |
| X4 PHARMACEUTICALS INC | COM NEW | $8.9M | 0.3%Prev: 0.3% | 2,233,742 SH | Increased |
| XENCOR INC | COM | $109.2M | 3.7%Prev: 1.3% | 7,133,720 SH | Increased+4,393,579 SH |
| XOMA ROYALTY CORPORATION | COM NEW | $68.9M | 2.3%Prev: 4.0% | 2,590,303 SH | Decreased |
| ZYMEWORKS INC | COM | $103.7M | 3.5%Prev: 2.7% | 3,938,641 SH | Increased |
| 13F-HR |
| 0000921895-26-002163 |
| $3.91B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000921895-25-002281 | $2.80B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000921895-26-001382 | $3.14B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000921895-25-001528 | $2.45B | View |